Cargando…
LB18. An Enveloped Virus-like Particle (eVLP) Cytomegalovirus (CMV) Vaccine Is Immunogenic and Safe: Results of a First-in-Humans Study
BACKGROUND: CMV is the most common cause of congenital infection and may result in permanent neurodevelopmental injury including vision and hearing loss. A vaccine to prevent transmission of CMV during pregnancy or to immunocompromised persons is a public health priority. Neutralizing antibodies (nA...
Autores principales: | Gantt, Soren, Quach, Caroline, Anderson, David E, Diaz-Mitoma, Francisco, Langley, Joanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253387/ http://dx.doi.org/10.1093/ofid/ofy229.2192 |
Ejemplares similares
-
LB17. Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
por: Hughes, Brenna
Publicado: (2019) -
Turnip Mosaic Virus Coat Protein Deletion Mutants Allow Defining Dispensable Protein Domains for ‘in Planta’ eVLP Formation
por: Yuste-Calvo, Carmen, et al.
Publicado: (2020) -
Proteome Investigation of Rat Lungs Subjected to Ex Vivo Perfusion (EVLP)
por: Roffia, Valentina, et al.
Publicado: (2018) -
Cytomegalovirus (CMV) Infection and Latency
por: O’Connor, Christine M.
Publicado: (2021) -
Distribution of CMV envelope glycoprotein B, H and N genotypes in infants with congenital cytomegalovirus symptomatic infection
por: Dong, Niuniu, et al.
Publicado: (2023)